These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2787424)

  • 1. [Molecular markers of hemostatic mechanisms--interaction of plasminogen activator and its inhibitor].
    Sakata Y
    Rinsho Byori; 1989 Mar; 37(3):256-60. PubMed ID: 2787424
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinolytic system of the skin: localization and modulation of plasminogen activator (PA) and PA inhibitor].
    Izaki S; Hibino T
    Rinsho Ketsueki; 1987 Jul; 28(7):1127-33. PubMed ID: 3121894
    [No Abstract]   [Full Text] [Related]  

  • 4. The absence of release of the plasminogen activator after venous occlusion in a Fletcher trait patient.
    Estelles A; Aznar J; España F
    Thromb Haemost; 1983 Feb; 49(1):66. PubMed ID: 6552103
    [No Abstract]   [Full Text] [Related]  

  • 5. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activation and endotoxin.
    N Engl J Med; 1989 Sep; 321(13):903-4. PubMed ID: 2788817
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH).
    Mahmoud M; Gaffney PJ
    Thromb Haemost; 1985 Jun; 53(3):356-9. PubMed ID: 3931284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fibrinolysis in thrombotic thrombocytopenic purpura.
    Kwaan HC
    Semin Hematol; 1987 Apr; 24(2):101-9. PubMed ID: 3110958
    [No Abstract]   [Full Text] [Related]  

  • 11. [Short-acting fibrinolysis in the etiology of venous thrombosis].
    Petäjä J; Myllylä G; Rasi V; Vahtera E
    Duodecim; 1988; 104(5):317-24. PubMed ID: 3139389
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 1 plasminogen activator inhibitor.
    Loskutoff DJ; Sawdey M; Mimuro J
    Prog Hemost Thromb; 1989; 9():87-115. PubMed ID: 2492381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liberation of plasminogen activators].
    Klöcking HP; Bock G; Drawert J; Hinsenbrock KP; Kaiser B; Sedlarik U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):404-24. PubMed ID: 63428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in fibrinolysis in liver cirrhosis].
    Fontcuberta J; Borrell M; Felez J; Elez I; López M; Remacha A; Rutllant ML
    Sangre (Barc); 1982; 27(4-B):727-36. PubMed ID: 6186038
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of inhibition of tissue-type plasminogen activator in blood.
    Collen D
    Thromb Haemost; 1983 Oct; 50(3):678. PubMed ID: 6417816
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic abnormalities of the fibrinolytic system.
    Aoki N
    Prog Clin Biol Res; 1981; 72():229-47. PubMed ID: 7199719
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
    Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
    J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological fibrinolysis.
    Fletcher AP
    Fed Proc; 1966; 25(1):84-8. PubMed ID: 4283650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.